Olmesartan+amlodipine+hydrochlorothiazide Velka (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan+amlodipine+hydrochlorothiazide Velka, is an ARB presented as a combination tablet for oral use. It treats hypertension, often in patients who require multiple mechanisms to control blood pressure. GNH USA supplies Olmesartan+amlodipine+hydrochlorothiazide Velca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan+amlodipine+hydrochlorothiazide Velka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan+amlodipine+hydrochlorothiazide is a triple‑component antihypertensive that acts on several pathways that regulate vascular tone and fluid balance. - Hypertension: improves blood pressure control when monotherapy is insufficient. - Resistant hypertension: provides additional lowering effect in patients not at target with two agents. - Hypertension with edema: counteracts calcium‑channel blocker‑induced peripheral edema. - Hypertension in diabetic patients: offers renoprotective benefits of an ARB combined with diuretic therapy. - Hypertension with concomitant volume overload: assists in reducing extracellular fluid volume. - Hypertension in elderly‑aged patients:

Common Side Effects: - Headache  -                     ...  ........  ....  …  ....  …  … … … ...  … ...  … … ... … … ... … ...  -   ... … ... ... .... … … ... ... ... … ... … … ... … ... ... … ...  g -  ... ... ... ... ... ... - ... ... ...  - ... ... - ...  Serious  g  g  g  g  g -  g -  g -  g -  g -  g -  g - 

Ol  t  ewline

   ewline  ""  g.

    ewline \